| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 24/02/2011 | 12h00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 24/02/2011 | 12h00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 24/02/2011 | 12h00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 23/02/2011 | 22h40 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 23/02/2011 | 22h40 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 23/02/2011 | 22h39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 23/02/2011 | 22h39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 23/02/2011 | 22h39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 23/02/2011 | 22h39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 23/02/2011 | 22h38 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 22/02/2011 | 23h06 | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:KG | King Pharmaceuticals, Inc. |
| 18/02/2011 | 22h09 | Edgar (US Regulatory) | Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR) | NYSE:KG | King Pharmaceuticals, Inc. |
| 18/02/2011 | 22h07 | Edgar (US Regulatory) | Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR) | NYSE:KG | King Pharmaceuticals, Inc. |
| 18/02/2011 | 22h05 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 18/02/2011 | 22h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 18/02/2011 | 22h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 18/02/2011 | 22h02 | Edgar (US Regulatory) | -National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25) | NYSE:KG | King Pharmaceuticals, Inc. |
| 15/02/2011 | 23h03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:KG | King Pharmaceuticals, Inc. |
| 15/02/2011 | 17h57 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NYSE:KG | King Pharmaceuticals, Inc. |
| 15/02/2011 | 01h07 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NYSE:KG | King Pharmaceuticals, Inc. |
| 14/02/2011 | 19h52 | Edgar (US Regulatory) | Schedule 13G | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 20h36 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 12h08 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 00h08 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 00h07 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 00h07 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 00h06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 00h06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 00h04 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 08/02/2011 | 15h34 | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:KG | King Pharmaceuticals, Inc. |